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The genetic basis of many common, multi-factorial conditions is increasingly being
understood but use of the knowledge created, raises major dilemmas for primary care.
Identification of individuals that may be genetically predisposed to serious medical
conditions provides the opportunity to offer screening or prophylactic treatment, for
early detection or prevention and delay in disease onset in many complex conditions.
We describe a new pilot service development to introduce genetic risk assessment for
a wide range of conditions to primary care, and discuss the findings from its evalua-
tion. The evaluation highlighted the issues about the incorporation of genetic risk
assessment in primary care. The results of the evaluation along with findings from
other studies, juxtaposed with the implications of developments in genetics suggest
that changes are required to accommodate the integration of genetic risk assessment
into primary care clinical practice. We discuss what these changes are, the benefits and
drawbacks, and whether primary care can and is ready to make the changes required,
further shifting the focus from disease treatment to disease prevention.
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Background
The rapidly developing corpus of scientific knowl-
edge is providing greater insight into the role of
genes in influencing the development and progress
of disease. This includes common diseases, regularly
observed on a daily basis in primary care, such as
cancer, cardiovascular disease, diabetes mellitus,
osteoporosis, polycystic kidney disease and hyper-
tension, where there are multiple risk factors
involved in causing the condition but genes can
often be a principal component in predisposition.
Recognizing individuals that may be genetically
predisposed to serious medical conditions has
potential to enable the manipulation of con-
tributory factors to reduce or minimize the
increased risk (Qureshi and Kai, 2008). Co-factors
that might be engineered to reduce risk include
environmental iatrogenic causes such as smoking
and obesity, cultural aspects such as number of
sexual partners or consanguinity in marriages and
diagnostic procedures such as repeated exposure
to radiation from mammography or dental X-rays.
Alternatively, high-risk groups (eg, BRCA1,
BRCA2 gene mutations which predispose to
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breast and other types of cancer) can be more
closely monitored to enable the identification of
disease at an earlier stage to maximize therapeutic
interventions to reduce the potential impact of a
disorder and where feasible, facilitate preventative
therapies.
Reducing the impact may result in reduction of
the acute and chronic long-term complications that
often develop as an outcome of disease progression
(Scheuner et al., 2004). This has major benefits
for the individual in terms of their quality of life,
their sustained economic earning capacity and
the impact this has on their family members. The
societal gain is a productive member of the work-
force, and a reduced economic burden of treating
serious disease and incapacity along with all the
repercussions that late onset disease-related dis-
ability can bring to individuals and their families.
To detect individuals that might be predisposed
to a particular disease, ideally a three-generation
family history is required which includes all family
members, illnesses that have affected them, age on
onset and their current age or age of death. Based
on the information obtained, it is possible to
undertake an assessment allowing stratification of
patients into differing genetic risk categories:
population risk (an average risk similar to that of
the general population), moderate or high risk.
Those at population risk can be given the health
and lifestyle advice that is applicable to the general
public. Those found to be at increased risk require
more ‘bespoke pathways’ or alternatively referral to
specialist genetic units where a more detailed risk
assessment can be made and personalized pro-
grammes of lifestyle advice, screening and mon-
itoring and prophylactic treatment measures may
be offered. This is based on the Kenilworth model
devised for managing patients in primary care
concerned about their family history of cancer
(Eeles et al., 2007).
The use of genetic risk information to improve
health has been a central tenet of the Department
of Health policy and planning for several years
(Department of Health, 2003). Many National
Service Frameworks and guidelines highlight the
importance of taking a family history for both
diagnostic purposes and for recognition of other
family members, who may share an increased risk,
to allow primary prevention measures to be
implemented (eg, lipid modification; NICE Clin-
ical Guideline 67). However, identifying those
individuals at risk has training and resource
implications. Specialist genetics services or sec-
ondary care do not have the capacity to under-
take a risk assessment of all people potentially at
risk. Therefore, many consider primary care as
the most viable setting for detecting and triaging
these individuals (Kinmonth et al., 1998; Watson
et al., 1999; Department of Health, 2003; Qureshi
et al., 2005), similar to the model successfully
applied to the field of cancer genetics.
General practice has always emphasized its role
in caring for the family as well as the patient. This
has previously meant treating the patient and sus-
taining their family unit with information and psy-
chological support in times of physical or mental
illness. However, there has been relatively little
focus on genetic disease and family history. Family
history taking in primary care has traditionally been
rudimentary (Rich et al., 2004), primarily focusing
on social structures and superficially on first degree
relatives of the patient, namely parents, siblings and
offspring. It often does not provide sufficient
information to undertake a fully informed genetic
risk assessment (Murff et al., 2004; Qureshi et al.,
2005) and where it does, this tends to be used in
isolation, without considering the environmental
factors and the gene–environment synergy that
causes disease (Hall et al., 2007).
Incorporating genetic risk into family history
taking in primary care enables clinicians to take a
holistic review, combining gene, environmental,
cultural and iatrogenic factors in their assess-
ments of disease risk for individuals and families.
Family based strategies for identifying family
members at risk contributes to further extending
the role of primary care in disease prevention and
health promotion, and provides opportunities to
identify those individuals who are most likely to
benefit from, and need to be targeted for,
increased screening and improved access to
health checks as outlined in the Government
agenda for the NHS (Brown, 2008).
General practitioners (GPs) also have an
important role in the successful utilization of
genetic risk assessment by patients because they
can initiate and catalyze health behaviour changes
by individuals (Rubak et al., 2005; Qureshi and Kai,
2008). Primary care also has the best and most
widespread access to the traditionally difficult to
reach groups and are the best positioned health
professionals to monitor continued concordance
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with health behaviour and screening recommen-
dations, and prophylactic treatment regimens.
Therefore, successful utilization of genetic risk
assessment is often dependent on embedding this
within primary care. However, following an eva-
luation we recently undertook as part of a pilot
service development, to ascertain the most effective
way to integrate genetic risk assessment into pri-
mary care for a range of common, multi-factorial
conditions including cardiac, renal and endocrine
diseases, a number of issues were identified.
The purpose of the evaluation was to:
i) describe the acceptability and feasibility of
genetic risk assessment tool specifically
designed for primary care (called ‘the family
history screening questionnaire’(FHSQ)), the
guidelines for the assessment and two differ-
ent referral pathways;
ii) evaluate patient anxiety and worry regarding
family history and the risk of inherited
genetic disease;
iii) ascertain primary care health professionals
opinions on the role of primary care in the
provision of genetic risk assessment;
iv) identify the barriers and facilitators to routine
provision of genetic risk assessment in pri-
mary care.
Briefly, 13 GPs from 13 practices (14% of prac-
tices invited to participate) in a local primary care
NHS trust initially volunteered to participate in a
project to integrate genetic risk assessment into their
practices, but only eight practices finally introduced
the pilot project to their practice (see Table 1).
The practices were varied in terms of the
number of GPs, their list size and Townsend
scores (Townsend et al., 1992) ranged from 18.58
(greatest level of material deprivation) to 4.2
(lowest level of material deprivation). The pilot
service development was deliberately aimed at a
district with many potential barriers to such pro-
grammes, including high levels of socio-economic
deprivation and high levels of non-English
speaking residents so that a realistic range and
scale of potential problems could be identified.
A variety of data collection tools were used to
meet the objectives. Qualitative semi-structured
interviews and focus groups were conducted to
ascertain health professionals’ opinions, views and
experiences of integrating genetic risk assessment
into their practices. Some practices also completed
a feedback questionnaire about the feasibility and
practicality of the genetic risk assessment form,
guidelines and appropriate referral of patients.
All participating patients were asked to com-
plete validated assessment tools (six-item short
form Spielberger State-Trait Anxiety Inventory
(STAI) and an adapted six-item worry scale
(Marteau and Bekker, 1992)) pre and post their
genetic risk assessment to collate self reported
changes in psychological well-being. Patients also
completed a nine-item questionnaire which
restricted them to yes, no or other categorical
responses about the views and experiences of
genetic risk assessment.
An initial FHSQ (see Appendix 1) consisted
of a series of questions regarding family history and
age of onset of cardiac, endocrine and renal dis-
ease, devised by a team of medical consultants with
expertise in these fields in conjunction with
a medical geneticist. The follow-up second ques-
tionnaire was developed to ascertain a more
detailed family history to include at least three
generations of both affected and unaffected family
members, age of diagnosis and current ages or age
of death for all family members. This second form
is based upon those used for identification and
management of patients at risk of developing
cancer in the West Midlands (West Midlands
Cancer Strategy (WMFACS) form, 2003).
Two different potential pathways for genetic
risk assessment were developed: a proactive
pathway and a reactive pathway. For the proactive
route, a member of the practice staff initiated
discussion about family history of cancer, cardiac,
endocrine or renal disease during routine con-
sultation, clinics or new patient checks. The reac-
tive pathway displayed posters in general practice
waiting rooms asking in lay terms whether
Table 1 Practice demographics
Practice Number of GPs List size Townsend
1 1 4737 13.52
2 8 6275 4.85
3 6 6716 16.28
4 3 3905 18.58
5 4 5442 11.73
6 6 6989 4.25
7 1 2951 11.73
8 3 4107 10.68
GPs5general practitioners.
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patients had a family history of a series of diseases.
If interested in having their family history
reviewed for inherited genetic risk, patients were
asked to leave their names and addresses for a
health professional to contact them. The four
practices that instituted the proactive pathway
also displayed posters in waiting areas.
During a time frame of six months, from Jan-
uary to June 2006, FHSQs were completed for 42
patients by six out of original eight participating
practices, of which 41 were returned to the eva-
luation team. Table 2 provides a breakdown of
which health professionals were involved in the
completion of FHSQs.
Twelve patients reported no family history of any
of the conditions described, nine said their family
was affected by one of the conditions listed and 16
reported a family history of more than one condi-
tion. Five FHSQs were not fully completed. From
this initial screening tool (FHSQ), health profes-
sionals identified 12 patients who required a fuller
genetic risk assessment of which only two were
followed up and a full family history was obtained
and referred to the local clinical genetics service.
The relatively poor response rate from GP
practices that had volunteered led to an exploration
of some of the reasons for this outcome. A number
of factors began to emerge which can begin to
explain the responses received.
Practice feedback
Primary care professionals completed 23 prac-
tice feedback forms of which eight (34%)
described problems with patient completion
mainly due to language barriers.
Eleven primary care professionals were inter-
viewed or took part in focus groups including five
GPs, two practice managers, two practice nurses
and two health care assistants, and these partici-
pants discussed the practicalities of integrating
genetic risk assessments into primary care practice.
Table 2 Implementation of family history and genetic risk assessment pathways
Discipline health
professionals
Approach to
identification
Variation of pathway FHSQ administered
to patients
Health care assistant Proactive No variation pathway fully implemented as designed 1
Two practice nurses Proactive Receptionist administered FHSQ to all patients
attending one of three nurse-lead clinics. Patients
were asked to complete them in the waiting room
and return to nurse during their consultation
17
Two health care
assistants
Proactive and
reactive
Poster displayed in waiting room and health care
assistant initiated discussion regarding family
history during consultations
3
Two health care
assistants
Proactive and
reactive
No new patients approached. Discussion initiated with
patients attending chronic disease clinics. Poster
displayed in waiting room and chronic disease clinic
15
GP Proactive and
reactive
GP initiated discussion regarding family history
during routine consultations
0
Practice nurse Proactive and
reactive
Poster displayed in waiting room and practice nurse
initiated discussion regarding family history during
routine consultations
6
None identified Reactive Poster displayed in waiting room, names and contact
details of interested patients recorded. Clinical
genetics unit sent family history screening
questionnaires to patients on the list
7
None identified Reactive Poster displayed in waiting room and chronic disease
clinic. Arrangement with the project co-ordinator for
review of family history when required
0
FHSQ5 family history screening questionnaire; GP5general practitioner.
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Perceived patient demand
The findings from the interviews showed that
GPs perceived little demand for genetic risk
assessment for cardiac, endocrine or renal disease
and suggested that patients have other priorities.
This was assumed by GPs because they said issues
of family history and inherited disease were rarely
raised by the patients during routine consulta-
tions. The only exceptions were for concerns for
an inherited predisposition to cancer or ante-
natally during pregnancy. Where concerns were
raised about family history and genetic predis-
position or causes, it was suggested that this was
triggered by the occurrence of disease or a death
in the family. Some also thought that patients did
not want information about the causes of disease
because many believed its occurrence was due to
fate or God’s will. Many believed that patients
were not interested in advice on preventing dis-
ease but were concerned only with having their
symptoms treated.
Many professionals from the project reported
limited confidence and competence in carrying
out a genetic risk assessment, from ascertaining a
suitable family history to assessing and stratifying
the risk for a wide range of conditions which may
arise as the result of a genetic predisposition.
The majority of professionals reported limited
experience of genetic disorders and making
referrals to the regional genetics service. How-
ever, some professionals said they routinely took
a family history during new patient consultations
but it was they, rather than the patient, who
initiated discussion about family.
It was thought that more guidance and support
was required to enable primary care health pro-
fessionals to identify patients and families that
might benefit from a referral to genetic specialist
services. There was a view that practice health
care assistants should incorporate family history
taking into the new patient registration con-
sultation and genetics specialists should review
them and provide risk assessments to be followed
up in primary care clinics, if necessary.
Current role of primary care
The majority of primary healthcare profes-
sionals agreed genetic risk assessment is clinically
relevant to their patients. However, they expres-
sed concerns about the practical implications;
whether it is possible to screen everyone in their
practice, including the feasibility of reaching all
patients on their lists, and the resource require-
ments. Many of the health professionals felt there
was a limited role for primary care, especially as
there were so many other competing require-
ments and clinical priorities in the sector. GPs
particularly recognized genetic risk assessment
would have benefits for patients and thought
primary care was best placed for collecting family
history information.
Utility of the family history screening tools in
routine primary care
Based upon their previous experience, most
professionals believed that patients would not know
and be able to accurately report their family history
and therefore would be unable to complete the
FHSQ without significant input from health pro-
fessionals. Language and literacy were specifically
perceived to be a problem for some patients. Some
GPs also suggested that patients would not recog-
nize a number of the conditions listed on the FHSQ
(sudden cardiac death, heart failure and osteo-
porosis) and they expressed concerns about asking
patients to take home and complete the full family
history questionnaire, which they thought they were
unlikely to be able to do.
Patients’ perspective
Half of the 41 patients (n5 22; 54%) completed
anxiety and worry scales. The mean STAI state
anxiety was 37.69 at baseline and following risk
assessment increased to 45.11. Worry scores
barely altered, 8.95 at baseline rising to 9.50. The
change in anxiety and worry observed between
risk assessment and baseline however was small
and unlikely to be clinically relevant (ie, a seven
unit change in anxiety on a 40-point scale and one
unit change in worry on an 18-point scale). Out of
the 20 patients surveyed with a patient percep-
tions questionnaire, 15 (75%) thought it would be
useful to know their genetic risks.
Implications of the emergent issues
The evaluation from this service development,
despite its limitations of size, identified a number
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of issues which have not been fully explored in
the literature in primary care genetics; the only
exception being that related to education and
training. The continued limited capability of pri-
mary care clinicians to carry out genetic risk
assessment due to a lack of genetics education
and training supports previous findings that better
education and increased awareness in relation to
genetics is required (Emery et al., 1999; Burton,
2003). There was a perceived need for greater
support and guidance from specialist genetic ser-
vices despite the simplicity of the assessment
proformas designed for both patient and clinician,
which were similar to versions currently used by
health professionals and patients in cancer
genetic risk assessment, where risk triaging is now
well established in primary care.
One problem identified for primary care relates
to the practicalities of carrying out genetic risk
assessment. Some patients will not necessarily
know what illnesses and conditions have affected
other family members beyond their parents and
siblings, and even then they may not fully recog-
nize the condition. Therefore, it was thought that
health care assistants, as a minimum, would be
required to assist patients with completing genetic
risk assessment forms, which can be time con-
suming. GPs were also concerned that carrying
out a genetic risk assessment, even if the relevant
information had been collated by other health
professionals, would be time consuming. Experi-
ence from cancer genetic pathways however has
shown that a small proportion of people have a
problem completing a family form, but in most
instances people are able to complete it if they
have time to contact relatives to obtain more
details. However, language and literacy barriers
would need to be considered in the assessment
process.
Many of the participating clinicians thought
that most patients are not really interested in
knowing whether they are at an increased risk
from illness based on their family history. These
views contrast significantly with referrals made
for a family history of cancer, which are most
commonly generated by patient request or GP
instigation, rather than hospital based referrals.
This may suggest that the problem to overcome is
one of perception or knowledge in relation to
genetics and other types of disease. The barrier is
more likely to be a lack of knowledge and access
to appropriate information. Patients have differ-
ent beliefs and understandings about disease and
causative factors (Walter and Emery, 2005; 2006)
and these require consideration in discussing
genetic risk information with them. Often, lay
people think that illness is inherited to some
degree, sometimes incorrectly so (Walter et al.,
2004). There is evidence that some patients are
interested in knowing more about the role of their
genes in causing a serious disease or having a test
for their susceptibility to serious diseases (The
Harris Poll, 2002; Buchanan et al., 2005; Vries
et al., 2005), but that when they raise it with their
GP, they are not necessarily given appropriate
information or advice (Metcalfe et al., 2007).
Patients may not raise the issue themselves for
several reasons, including limited awareness of
options to prevent or delay onset of multi-
factorial conditions and expectations that their
doctor will tell them if they need to consider their
family history. Further work to ascertain patients’
level of interest in having their genetic predis-
position identified may be relevant for informing
future service developments, sub-stratified by
gender, ethnicity and disease type (based on
associated morbidity and mortality), and the
availability of preventative therapies.
However, a more fundamental consideration
emerged. The successful integration of genetic
risk assessment into primary care is dependent on
further changes in focus from treatment to pre-
vention. A highly contentious point of debate in
primary care at present is whether the budget and
resource should shift to focus on prevention of
disease and ill-health, or remain primarily
focused on the sick and ill patients. The balance
between resources for those affected by disease
and ill health versus that of prevention is a com-
plex debate; and to refocus on prevention
requires the will and resource to enable it to
happen. Many of the participants thought genetic
risk assessment could potentially be useful to
patients but they were unsure of how genetic risk
assessment could bring benefits to primary care
provision when there are so many other compet-
ing priorities. This raises important questions:
what is the focus of primary care? And if the
benefits to healthy patients are to be fully realized
without detriment to those already sick, how does
primary care turn its attention to integrating
new technological developments that require a
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reappraisal of its processes and function from
treating disease to its prevention?
Incorporation of genetic risk assessment into
primary care is not new. In cancer, for example,
many GPs carry out an initial risk assessment
before deciding whether to refer patients to
specialist genetics units because of their family
history. However, there appears to be less incli-
nation to carry out genetic risk assessments for
other diseases, some of which have higher mor-
bidity and mortality rates than cancer (eg, cardio-
vascular disease), despite options of prevention
and early detection being available which may
reduce socio-economic costs related to the man-
agement of future disease.
Primary care would appear to be the obvious
setting for carrying out genetic risk assessment.
Primary care health professionals have regular
contact with the majority of their patients and
could routinely collate family histories and iden-
tify those who are likely to be genetically pre-
disposed to common multi-factorial conditions.
This ongoing contact means that GPs also have
the most opportunities to influence healthy life-
style behaviours and promote concordance with
screening or prophylactic treatments. Also, as
patients develop a growing awareness of genetic
risk factors, it is from GPs that they are most
likely to request further information. This was
illustrated in the field of cancer genetics where
service development was initially driven by
patient demand. Secondary care activities
increasingly use genetic testing (eg, BRCA 1 or
BRCA 2 mutation testing) to predict patients’
responses to some cancer treatments, thereby
removing their choice about genetic testing. This
has implications for all siblings and children of
the person tested because they are at risk from
carrying the same gene that predisposed them
to breast cancer. Primary care is likely to be the
first point of access for the family members who
may want genetic testing to ascertain their own
predisposition. In future, it is likely that the
management of other diseases will include gene
mutation studies to identify the best course of
treatment with similar implications for the blood
relatives of these genetically tested individuals.
Including genetic risk assessment in primary
care does have further challenges. A way of
recording, assessing and updating family histories
of patients is required, and this has resource
implications. There have been efforts to develop
tools for genetic risk assessment in primary care
but they have generally had only limited success
(Qureshi et al., 2005; 2007; Emery et al., 2007).
The focus of genetic risk assessment also has
potential adverse effects in the medicalization of
the healthy and raising anxieties, both of which
have a resource implication in terms of time to
support individuals and allay unnecessary fears
and concerns, but also the costs of prophylactic
treatment and screening for those individuals that
might never develop the condition.
Despite the drawbacks, there are potentially
many benefits of integrating genetic risk assess-
ment within primary care. Better information of
an individual’s risk of future disease that is
derived from genetics and environmental factors
can improve care through raised awareness of
healthy life style choices and prophylactic treat-
ment in the individual, and allow targeted
screening of individuals at increased risk rather
than screening programmes for the general
populous. With the present government focus on
screening (Brown, 2008), family risk assessment
including a genetic history will provide a strong
evidence basis for cost-effective targeting of those
individuals who are most likely to be at risk from
a specific condition. Finally, better genetic risk
assessment within family history taking will assist
with identifying those at risk from monogenic
conditions, pre-conception and prenatally to
allow a more informed discussion of the risks
associated with pregnancy and the health impli-
cations to both mother and child.
Future work required
In light of the issues raised by GPs, there is clearly
further work required to examine the implica-
tions of integrating genetic risk assessment into
primary care practice. Some steps have been
taken to improve education and awareness of
genetics in general practice; GPs with a special
interest in genetics (GPwSI Genetics) were
appointed to develop ‘professional leadership,
education of peers and provide strategic advice to
PCTs’ (NHS National Genetics Education and
Development Centre, 2007). This ‘snapshot’ sug-
gests there is still much more education and
training required. Further studies are required to
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establish the patients’ need for genetic risk
assessment, where it is required, examine differ-
ent models of service delivery in collating family
(including genetic) history information and
assessment of risk, including utilization of new
information and computing technologies. A variety
of models have been described earlier, ranging
from use of specialist nurses in primary or
secondary care to the use of information tech-
nologies (Eeles et al., 2007; Elwyn et al., 2005).
However, there would appear to be a consensus
that the success of different models is variable
because it depends on the needs of the local
community, resource availability and motivation
of clinicians to engage in this area of practice.
Therefore, further work is required with local
communities to establish their priorities and ser-
vice model preferences and long-term work is
also required to establish whether genetic risk
assessment is beneficial and effective clinically
and economically to individuals and wider society.
Summary
In this paper, we have tried to discuss the devel-
opment of new services to integrate more genetic
risk assessment in primary care, in the context of
a discussion about the benefits and drawbacks of
its introduction for a range of diseases that might
be prevented or their onset delayed, if risks are
identified and prophylactic actions taken.
As a result of our evaluation findings, we high-
light a number of factors that need to be con-
sidered, including an increasingly difficult dilemma
of balancing the care of the sick and preventing
future disease, and consideration of the resources
required to carry out a genetic risk assessment and
education and training of primary care health pro-
fessionals to undertake it. Simple pathways and
triggers will also be required so as not to burden
primary care with resultant unmanageable work-
loads or unrealistic knowledge requirements.
We conclude that primary care is the most
appropriate place to undertake an initial genetic
risk assessment to identify those who are at
increased risk and who would benefit from
referral to specialist genetics centres. However,
primary care will need to evolve to incorporate
and integrate the developments in genetics, which
are increasingly being applied to clinical practice.
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Appendix 1
Coordinated by the West Midlands Regional Genetics 
Service 
Birmingham Women’s Health Care 
NHS Trust
In collaboration with 
Heart of Birmingham Teaching 
Primary Care Trust
University Hospital Birmingham 
NHS Foundation Trust
TO BE COMPLETED BY INDIVIDUALS AGED 18 AND OVER ONLY
Please fill in your personal details below: 
Full name: 
Date of birth: Post code: 
Please indicate whether you or any of your close blood relatives* have had any of the 
following medical conditions at (or under) the age specified. 
*Close blood relatives are your mother, father, brothers and sisters (full or half), aunts and 
uncles and grandparents  
 Medical condition Age Please circle ‘Yes’ or 
‘No’
1  oN / seY rednu ro 05  kcatta traeH
2  oN / seY rednu ro 05  htaed caidrac nedduS
3 Cardiomyopathy (enlarged heart) Any age Yes / No 
4 Any other type of heart disease e.g. heart failure 50 or under Yes / No 
5 Kidney disease and/or had kidney dialysis Any age Yes / No 
6  oN / seY rednu ro 05 erusserp doolb hgiH
7  oN / seY rednu ro 05 ekortS
8 Osteoporosis (soft, fragile or brittle bones) 75 or under Yes / No 
9  oN / seY rednu ro 57  erutcarf piH
10  oN / seY ega ynA setebaiD
11 Have you or any of your blood relatives had a 
genetic test or attended a genetic clinic? 
Any age Yes / No 
Family History Short Form 
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